• Independence Day
  • About BreezyScroll
  • Privacy & Policy
  • Contact Us
Friday, November 20, 2026
BreezyScroll
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra
No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra
No Result
View All Result
BreezyScroll
No Result
View All Result

Home  /  Health  /  WHO issues global alert on fake versions of diabetes medicine, Ozempic

WHO issues global alert on fake versions of diabetes medicine, Ozempic

by Jonathan Campbell
June 21, 2024
in Health, World
Reading Time: 2 mins read
WHO issues global alert on fake diabetes medicine, Ozempic

Counterfeit Diabetes and Weight Loss Medications Pose Severe Health Risks

The World Health Organization (WHO) issued a global alert on June 20, warning against counterfeit versions of Ozempic, a type 2 diabetes medication increasingly used for weight loss. The UN health agency cited an increased demand for these medications alongside reports of falsifications that could pose significant health risks.

Fake batches discovered

In its alert, WHO identified three falsified batches of Ozempic found in Brazil, Northern Ireland, and the United States between October 2023 and December 2023. The organization emphasized the importance of purchasing medications only from reliable sources, such as licensed medical professionals, rather than online or through social media.

“WHO advises healthcare professionals, regulatory authorities, and the public to be aware of these falsified batches of medicines,” stated Dr. Yukiko Nakatani, WHO assistant director-general for essential medicines and health products. “We call on stakeholders to stop any usage of suspicious medicines and report to relevant authorities.”

ADVERTISEMENT

Risks of fake Ozempic

The counterfeit drugs purport to contain semaglutide, the active ingredient in Novo Nordisk’s Ozempic, which helps control blood sugar in type 2 diabetes patients and aids weight loss by suppressing appetite. WHO warned that these fake medications might lack essential components, potentially leading to unmanaged blood glucose levels or ineffective weight control.

Pharmaceutical companies respond

American pharmaceutical company Eli Lilly expressed “deep concern” over the sale of fake or compounded versions of tirzepatide, an active ingredient in its Mounjaro and other GLP-1 drugs. On Thursday, Eli Lilly announced it had sued six entities, including medical spas and wellness centers, for selling products claiming to contain tirzepatide.

Similarly, Novo Nordisk has taken legal action against several entities to halt the sale of products falsely claiming to contain semaglutide.

Tags: Ozempic
ShareTweetShareSend
ADVERTISEMENT

Recent Articles

Older men and women with arms outstretched during an exercise class in a community hall

Higher BMI After 65 Tracked Lower Death Risk. Waist Didn’t

November 18, 2026
The Pitt Building, the Gothic-revival home of Cambridge University Press on Trumpington Street in Cambridge

Cambridge Dictionary’s 2026 Word of the Year Is ‘Human’

November 18, 2026
A limousine and a police car at the entrance of the Shenzhen International Exchange Center beside an APEC China 2026 sign

Shenzhen Offered One Household $1,500 to Leave During APEC

November 18, 2026
Two men stand in the plant-filled ground-floor lobby of Anthropic's San Francisco office, with wooden seating booths on either side

Anthropic Researcher Says AI Will Make Humans Unemployable

November 18, 2026
BreezyScroll Logo

BreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.

Follow Us

Browse by Category

  • Africa
  • Alaska
  • Animals
  • Asia
  • Athletics
  • Australia
  • Auto
  • Basketball
  • Bollywood
  • Brand
  • Breezy Explainer
  • Breezy Feature
  • Breezy Soul
  • Business
  • Canada
  • Chess
  • China
  • Cricket
  • DIY
  • Education
  • Entertainment
  • Environment
  • EPL
  • Europe
  • Exclusive Interview
  • Exclusive Review
  • Football
  • Gaming
  • Health
  • Hollywood
  • India
  • International
  • K Pop
  • Law
  • Lifestyle
  • Middle East
  • Money
  • NFL
  • North America
  • OTT
  • Paris Olympics
  • Pets
  • Russia
  • Science
  • South America
  • Space
  • Sports
  • Startup
  • Technology
  • Tennis
  • Tennis
  • The Achievers
  • The US
  • Travel
  • UK
  • UK
  • Uncategorized
  • World
  • WWE

Trending Topics

AI Apple Artificial Intelligence Australia Biden California Canada ChatGPT China Climate Change Donald Trump Elon Musk FBI Featured Florida Google IPL Iran Japan Joe Biden Mars Meta Moon NASA NBA Netflix New York North Korea Ohio OpenAI Putin Russia Russia-Ukraine crisis South Korea SpaceX Taliban Tesla Texas TikTok Trump Twitter UFO UK Ukraine Virat Kohli

No Result
View All Result
  • About BreezyScroll
  • Breezy Stories
  • Contact Us
  • Corrections Policy
  • Editorial Policy and Standards
  • Masthead
  • Privacy Policy
  • World News – Latest News Today | BreezyScroll

© 2024 · BreezyScroll.com

No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra

© 2024 · BreezyScroll.com

Go to mobile version